Healthcare -
Biotechnology - NASDAQ - US
$ 30.75
-0.646 %
$ 13.7 B
Market Cap
12.11
P/E
RPRX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities RPRX - Royalty Pharma plc
-2.15 B
LAST VALUE
-156.51%
2 YEAR CAGR
-9.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR